Beryl Drugs Limited (BOM:524606)

Market Cap	96.87M
Revenue (ttm)	211.46M
Net Income (ttm)	5.79M
Shares Out	5.07M
EPS (ttm)	1.14
PE Ratio	16.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,295
Average Volume	3,103
Open	18.20
Previous Close	19.14
Day's Range	18.20 - 20.09
52-Week Range	17.35 - 46.00
Beta	0.10
RSI	45.02
Earnings Date	May 30, 2025

About Beryl Drugs

Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services. The company also exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.

• Industry: Pharmaceutical Preparations
• Founded: 1993
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524606

Financial Performance

In 2024, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.68%.